MHRA and BAAPS release press statements on PIP breast implants

 

The MHRA and BAAPS have issued press statements following the publication of French regulator AFSSAPS’ worrying results into the safety of PIP Breast Implants

 

30 I 09 I 10

Bookmark and Share

 

For more PIP news stories visit our dedicated PIP page


The Medicines and Healthcare products Regulatory Agency, MHRA (http://www.mhra.gov.uk/) and the British Association of Aesthetic Plastic Surgeons (BAAPS) (http://www.baaps.gov.uk/) have issued press statements in response to the worrying results released by the French regulator, AFSSAPS’ following the testing into the safety of PIP breast implants.

 

AFSSAPS conclude that their testing shows that the performance and safety of PIP prostheses are not in accordance with current expected standard. Please click here to read our full story on the release of the French results.

 

The MHRA Clinical Director for Devices, Dr Susanne Ludgate has stated that “It is important that we inform implanted women in the UK of these findings. We are currently seeking further advice from UK clinical and toxicology experts following publication of these results. In the meantime, if women have any concerns they should speak to their implanting surgeon”.

BAAPS President Nigel Mercer has commented that:

“The BAAPS continues to recommend that women who’ve undergone breast augmentation contact their surgeons to find out what type of implant was used. If it’s PIP they should have an ultrasound in the next six months to establish whether there is any weakening or rupture. Removal of both implants is recommended in these cases.”

Mark Harvey is now representing approximately 170 clients in relation to concerns over the safety of PIP breast implants.  Mr Harvey has already contacted all of his clients to update them on these worrying results.

 

Please click the link below to read  the AFSSAPS press release: http://www.afssaps.fr/var/afssaps_site/storage/original/application/38fbe37bdd1897eb09de4f892a317c14.pdf

 

Please click the link below to to the full MHRA press release:

http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON094170

 

Please click the link below to read the full BAAPS full press release:

http://www.baaps.org.uk/about-us/press-releases/763-french-implants-test-inconclusive

Contact

Mark Harvey colourMark Harvey

Partner, Head of the Claimant Division

Head of Harmful Products and Overseas Accidents Team

 

E mark.harvey@hughjames.com

T 029 2039 1174

Design by Brand 68 | Development by Fusionworkshop | SEO by Pinnacle Internet Marketing